Variant report
Variant | esv2764266 |
---|---|
Chromosome Location | chr1:158700732-158725880 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:77)
- CpG islands (count:306)
- Chromatin interactive region (count:14)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr1:158704604-158704729 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr1:158709982-158710193 | K562 | blood: | n/a | n/a |
3 | ARID3A | chr1:158702324-158702669 | K562 | blood: | n/a | n/a |
4 | BACH1 | chr1:158701798-158702048 | K562 | blood: | n/a | n/a |
5 | BHLHE40 | chr1:158701588-158702091 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr1:158722945-158723184 | H1-hESC | embryonic stem cell: | n/a | chr1:158723040-158723051 chr1:158723037-158723054 chr1:158723040-158723053 |
7 | CEBPB | chr1:158722946-158723214 | HepG2 | liver: | n/a | chr1:158723040-158723051 chr1:158723037-158723054 chr1:158723040-158723053 |
8 | CEBPB | chr1:158722931-158723169 | IMR90 | lung: | n/a | chr1:158723040-158723051 chr1:158723037-158723054 chr1:158723040-158723053 |
9 | CEBPB | chr1:158722871-158723208 | K562 | blood: | n/a | chr1:158723040-158723051 chr1:158723037-158723054 chr1:158723040-158723053 |
10 | CEBPB | chr1:158719042-158719256 | HepG2 | liver: | n/a | chr1:158719183-158719196 chr1:158719183-158719194 |
11 | CEBPB | chr1:158719103-158719306 | A549 | lung: | n/a | chr1:158719183-158719196 chr1:158719183-158719194 |
12 | CEBPB | chr1:158711092-158711357 | K562 | blood: | n/a | n/a |
13 | CEBPB | chr1:158705115-158705187 | K562 | blood: | n/a | n/a |
14 | CEBPB | chr1:158722864-158723064 | A549 | lung: | n/a | chr1:158723040-158723051 chr1:158723037-158723054 chr1:158723040-158723053 |
15 | CEBPB | chr1:158722942-158723176 | Hela-S3 | cervix: | n/a | chr1:158723040-158723051 chr1:158723037-158723054 chr1:158723040-158723053 |
16 | CEBPD | chr1:158702210-158702773 | K562 | blood: | n/a | n/a |
17 | CEBPD | chr1:158702247-158702768 | K562 | blood: | n/a | n/a |
18 | CHD2 | chr1:158707497-158707550 | K562 | blood: | n/a | n/a |
19 | CTCF | chr1:158703490-158703560 | GM20000 | blood: | n/a | n/a |
20 | CTCF | chr1:158722200-158722406 | K562 | blood: | n/a | n/a |
21 | CTCF | chr1:158722251-158722361 | K562 | blood: | n/a | n/a |
22 | E2F4 | chr1:158711498-158711698 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | EBF1 | chr1:158703222-158703483 | GM12878 | blood: | n/a | chr1:158703323-158703334 |
24 | EP300 | chr1:158708315-158708350 | K562 | blood: | n/a | n/a |
25 | EP300 | chr1:158701733-158702739 | K562 | blood: | n/a | n/a |
26 | FOS | chr1:158711099-158711423 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | FOS | chr1:158711179-158711378 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | FOS | chr1:158711096-158711426 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | FOS | chr1:158711089-158711418 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | GATA1 | chr1:158701669-158703049 | PBDE | blood: | n/a | n/a |
31 | GATA1 | chr1:158701610-158702854 | K562 | blood: | n/a | n/a |
32 | GATA1 | chr1:158713956-158714405 | PBDE | blood: | n/a | n/a |
33 | GATA2 | chr1:158702273-158702678 | K562 | blood: | n/a | n/a |
34 | GTF2B | chr1:158703657-158703957 | K562 | blood: | n/a | n/a |
35 | HCFC1 | chr1:158710216-158710334 | K562 | blood: | n/a | n/a |
36 | IRF1 | chr1:158702162-158702644 | K562 | blood: | n/a | n/a |
37 | IRF1 | chr1:158708175-158708320 | K562 | blood: | n/a | n/a |
38 | IRF1 | chr1:158700228-158700835 | K562 | blood: | n/a | chr1:158700449-158700470 |
39 | JUN | chr1:158705356-158705898 | K562 | blood: | n/a | n/a |
40 | JUND | chr1:158710040-158710132 | K562 | blood: | n/a | n/a |
41 | JUND | chr1:158701502-158702695 | K562 | blood: | n/a | n/a |
42 | JUND | chr1:158705212-158705235 | K562 | blood: | n/a | n/a |
43 | MAFK | chr1:158713233-158713398 | HepG2 | liver: | n/a | n/a |
44 | MAFK | chr1:158711748-158711948 | HepG2 | liver: | n/a | chr1:158711865-158711885 |
45 | MAFK | chr1:158713144-158713371 | HepG2 | liver: | n/a | n/a |
46 | MAFK | chr1:158709573-158709727 | HepG2 | liver: | n/a | n/a |
47 | MAX | chr1:158701488-158701801 | K562 | blood: | n/a | n/a |
48 | MXI1 | chr1:158709411-158709426 | K562 | blood: | n/a | n/a |
49 | MYC | chr1:158701594-158701767 | K562 | blood: | n/a | n/a |
50 | NR2F2 | chr1:158702383-158702674 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:158725300-158725350 | H1-hESC | embryonic stem cell: | embryo |
2 | chr1:158725300-158725350 | H1-hESC | embryonic stem cell: | embryo |
3 | chr1:158723939-158723989 | LNCaP | prostate: | n/a |
4 | chr1:158723939-158723989 | ECC-1 | luminal epithelium: | n/a |
5 | chr1:158723939-158723989 | Jurkat | blood: | n/a |
6 | chr1:158723939-158723989 | HUVEC | blood vessel: | n/a |
7 | chr1:158725300-158725350 | CMK | blood: | n/a |
8 | chr1:158724794-158724844 | CMK | blood: | n/a |
9 | chr1:158725300-158725350 | NB4 | blood: | n/a |
10 | chr1:158724794-158724844 | MCF10A-Er-Src | breast: | n/a |
11 | chr1:158723939-158723989 | SK-N-MC | brain: | n/a |
12 | chr1:158723939-158723989 | HEK293 | kidney: | embryo |
13 | chr1:158723939-158723989 | MCF10A-Er-Src | breast: | n/a |
14 | chr1:158725300-158725350 | HMEC | breast: | n/a |
15 | chr1:158724794-158724844 | HMEC | breast: | n/a |
16 | chr1:158724794-158724844 | HUVEC | blood vessel: | n/a |
17 | chr1:158724362-158724412 | GM19239 | blood: | n/a |
18 | chr1:158723939-158723989 | RPTEC | kidney: | n/a |
19 | chr1:158724362-158724412 | CMK | blood: | n/a |
20 | chr1:158723939-158723989 | HL-60 | blood: | n/a |
21 | chr1:158724057-158724107 | HCM | heart: | n/a |
22 | chr1:158725300-158725350 | GM12878 | blood: | n/a |
23 | chr1:158725300-158725350 | RPTEC | kidney: | n/a |
24 | chr1:158725300-158725350 | HRE | kidney: | n/a |
25 | chr1:158724362-158724412 | HCPEpiC | choroid plexus: | n/a |
26 | chr1:158724794-158724844 | ECC-1 | luminal epithelium: | n/a |
27 | chr1:158725300-158725350 | GM12892 | blood: | n/a |
28 | chr1:158724057-158724107 | GM12878 | blood: | n/a |
29 | chr1:158724362-158724412 | HRE | kidney: | n/a |
30 | chr1:158724057-158724107 | AG09319 | gingival: | n/a |
31 | chr1:158724794-158724844 | PFSK-1 | brain: | n/a |
32 | chr1:158724057-158724107 | HRPEpiC | eye: | n/a |
33 | chr1:158724057-158724107 | MCF10A-Er-Src | breast: | n/a |
34 | chr1:158725300-158725350 | Caco-2 | colon: | n/a |
35 | chr1:158725300-158725350 | HCT-116 | colon: | n/a |
36 | chr1:158725300-158725350 | AG09319 | gingival: | n/a |
37 | chr1:158724362-158724412 | Jurkat | blood: | n/a |
38 | chr1:158725300-158725350 | HEK293 | kidney: | embryo |
39 | chr1:158723939-158723989 | HCPEpiC | choroid plexus: | n/a |
40 | chr1:158724794-158724844 | BJ | skin: | n/a |
41 | chr1:158724362-158724412 | SKMC | muscle: | n/a |
42 | chr1:158724362-158724412 | NB4 | blood: | n/a |
43 | chr1:158723939-158723989 | NHDF-neo | bronchial: | n/a |
44 | chr1:158724057-158724107 | PrEC | prostate: | n/a |
45 | chr1:158725300-158725350 | T-47D | breast: | n/a |
46 | chr1:158724362-158724412 | LNCaP | prostate: | n/a |
47 | chr1:158724057-158724107 | NT2-D1 | testis: | n/a |
48 | chr1:158724362-158724412 | BE2_C | brain: | n/a |
49 | chr1:158724362-158724412 | RPTEC | kidney: | n/a |
50 | chr1:158725300-158725350 | BE2_C | brain: | n/a |
(count:14 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:158715265..158717778-chr1:158778694..158781362,2 | K562 | blood: | |
2 | chr1:158699118..158701949-chr1:158709331..158711984,2 | K562 | blood: | |
3 | chr1:158696982..158701883-chr1:158702210..158705771,7 | K562 | blood: | |
4 | chr1:158699118..158701949-chr1:158709331..158711984,2 | K562 | blood: | |
5 | chr1:158701755..158705583-chr1:158706296..158709041,3 | K562 | blood: | |
6 | chr1:158711568..158713375-chr1:158713499..158715477,2 | K562 | blood: | |
7 | chr1:158702009..158703945-chr1:158717255..158718973,2 | K562 | blood: | |
8 | chr1:158697116..158699497-chr1:158702619..158704927,2 | K562 | blood: | |
9 | chr1:158696982..158701883-chr1:158702210..158705771,7 | K562 | blood: | |
10 | chr1:158704822..158706927-chr1:158777581..158780196,2 | K562 | blood: | |
11 | chr1:158701755..158705583-chr1:158706296..158709041,3 | K562 | blood: | |
12 | chr1:158702009..158703945-chr1:158717255..158718973,2 | K562 | blood: | |
13 | chr1:158701358..158703864-chr1:158711036..158713684,2 | K562 | blood: | |
14 | chr1:158653549..158656527-chr1:158701529..158703994,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR6K5P | TF binding region |
OR6K6 | TF binding region |
OR6K5P | CpG island |
OR6K6 | CpG island |
ENSG00000163554 | chromatin interactions |
ENSG00000180409 | chromatin interactions |
ENSG00000226949 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs703147 | chr1:158700732-158700733 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs538397388 | chr1:158700856-158700857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550110487 | chr1:158700861-158700862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568710034 | chr1:158700909-158700910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs703148 | chr1:158700972-158700973 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs326005 | chr1:158701010-158701011 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs187373441 | chr1:158701011-158701012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192090399 | chr1:158701018-158701019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558190383 | chr1:158701019-158701020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369853513 | chr1:158701024-158701025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576462237 | chr1:158701026-158701027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543573511 | chr1:158701038-158701039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs386635929 | chr1:158701058-158701059 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201784130 | chr1:158701067-158701068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374274020 | chr1:158701071-158701072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369760474 | chr1:158701072-158701073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs74403289 | chr1:158701096-158701097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs326006 | chr1:158701200-158701201 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs540907590 | chr1:158701229-158701230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559271641 | chr1:158701240-158701241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532758549 | chr1:158701298-158701299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375925039 | chr1:158701320-158701321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74427709 | chr1:158701321-158701322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563349334 | chr1:158701417-158701418 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs16840748 | chr1:158701420-158701421 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs1930261 | chr1:158701449-158701450 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs568656502 | chr1:158701466-158701467 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs565731614 | chr1:158701472-158701473 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs370851129 | chr1:158701523-158701524 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs140451900 | chr1:158701525-158701526 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs113369942 | chr1:158701603-158701604 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs374156557 | chr1:158701614-158701615 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs77800865 | chr1:158701660-158701661 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs539796820 | chr1:158701661-158701662 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs150393890 | chr1:158701662-158701663 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs570097264 | chr1:158701725-158701726 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs145269356 | chr1:158701732-158701733 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs326007 | chr1:158701762-158701763 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs549787375 | chr1:158701785-158701786 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs78865107 | chr1:158701817-158701818 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs1953068 | chr1:158701841-158701842 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs183396253 | chr1:158701861-158701862 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs149160327 | chr1:158701875-158701876 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs544961156 | chr1:158701900-158701901 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs576247442 | chr1:158701904-158701905 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs563153667 | chr1:158701910-158701911 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs115366506 | chr1:158701978-158701979 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs146851315 | chr1:158702032-158702033 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs186598181 | chr1:158702047-158702048 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs112837228 | chr1:158702080-158702081 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21045282 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:158692600-158735200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr1:158698600-158701800 | Enhancers | K562 | blood |
3 | chr1:158700600-158701000 | Enhancers | Liver | Liver |
4 | chr1:158701800-158702000 | Flanking Active TSS | K562 | blood |
5 | chr1:158701800-158702200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr1:158702000-158702400 | Enhancers | K562 | blood |
7 | chr1:158702400-158702800 | Flanking Active TSS | K562 | blood |
8 | chr1:158702800-158706200 | Enhancers | K562 | blood |
9 | chr1:158705600-158705800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr1:158705600-158706000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
11 | chr1:158706200-158708000 | Weak transcription | K562 | blood |
12 | chr1:158708000-158708800 | Enhancers | K562 | blood |
13 | chr1:158708800-158709600 | Weak transcription | K562 | blood |
14 | chr1:158709600-158709800 | Active TSS | K562 | blood |
15 | chr1:158709800-158710000 | Flanking Active TSS | K562 | blood |
16 | chr1:158710000-158710200 | Enhancers | K562 | blood |
17 | chr1:158721800-158722200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr1:158722400-158724800 | Enhancers | Fetal Heart | heart |